1. Home
  2. KLTR vs LCTX Comparison

KLTR vs LCTX Comparison

Compare KLTR & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

N/A

Current Price

$1.32

Market Cap

218.0M

Sector

Technology

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$0.89

Market Cap

255.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KLTR
LCTX
Founded
2006
1990
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.0M
255.4M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
KLTR
LCTX
Price
$1.32
$0.89
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$3.50
★ $5.50
AVG Volume (30 Days)
175.8K
★ 1.3M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.90
N/A
EPS
N/A
N/A
Revenue
★ $180,854,000.00
$14,556,000.00
Revenue This Year
$1.74
$4.38
Revenue Next Year
$4.18
$10.80
P/E Ratio
★ N/A
N/A
Revenue Growth
1.20
★ 53.24
52 Week Low
$1.06
$0.91
52 Week High
$2.05
$2.09

Technical Indicators

Market Signals
Indicator
KLTR
LCTX
Relative Strength Index (RSI) 28.64 39.85
Support Level $1.23 $0.91
Resistance Level $1.53 $1.18
Average True Range (ATR) 0.04 0.06
MACD -0.01 -0.01
Stochastic Oscillator 0.00 21.30

Price Performance

Historical Comparison
KLTR
LCTX

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: